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Most radiotracers used in dynamic positron emission tomography
(PET) scanning act in a linear time-invariant fashion so that the mea-
sured time-course data are a convolution between the time course of
the tracer in the arterial supply and the local tissue impulse response,
known as the tissue residue function. In statistical terms the residue
is a life table for the transit time of injected radiotracer atoms. The
residue provides a description of the tracer kinetic information mea-
surable by a dynamic PET scan. Decomposition of the residue function
allows separation of rapid vascular kinetics from slower blood-tissue
exchanges and tissue retention. For voxel-level analysis, we propose
that residues be modeled by mixtures of nonparametrically derived
basis residues obtained by segmentation of the full data volume. Spa-
tial and temporal aspects of diagnostics associated with voxel-level
model fitting are emphasized. Illustrative examples, some involving
cancer imaging studies, are presented. Data from cerebral PET scan-
ning with 18F fluoro-deoxyglucose (FDG) and 15O water (H2O) in
normal subjects is used to evaluate the approach. Cross-validation is
used to make regional comparisons between residues estimated using
adaptive mixture models with more conventional compartmental mod-
eling techniques. Simulations studies are used to theoretically examine
mean square error performance and to explore the benefit of voxel-level
analysis when the primary interest is a statistical summary of regional
kinetics. The work highlights the contribution that multivariate anal-
ysis tools and life-table concepts can make in the recovery of local
metabolic information from dynamic PET studies, particularly ones
in which the assumptions of compartmental-like models, with residues
that are sums of exponentials, might not be certain.
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1. Introduction. Dynamic PET studies provide the opportunity to im-
age functional metabolic parameters of tissue in-vivo [Phelps (2000)]. Al-
though there have been many developments in this direction [e.g., Cun-
ningham and Jones (1993), Murase (2003), O’Sullivan (1993), Muzi et al.
(2012), Veronese et al. (2013)], no procedure has yet been widely adopted
for routine use. Most often quantitation of dynamic PET studies is based
on consideration of a single time point for a user-defined region of interest
(ROI). In view of the complexity of PET imaging and its expense, this is
unsatisfactory. As most radiotracers used in PET act in a linear and time-
invariant fashion, dynamic PET imaging measures the convolution between
the activity of the tracer in the arterial blood supply and the tissue impulse
response. The impulse response is known as the tissue residue function. In
statistical terms the residue is the life table associated with the collection of
PET tracer atoms introduced, typically by intravenous injection, to the cir-
culatory system. The residue has its roots in the seminal indicator dilution
work of Meier and Zierler (1954). Kinetic analysis of PET data is substan-
tially concerned with modeling and estimation of the residue function. To
this end, there are a suite of commonly used compartmental models [Huang
and Phelps (1986)]. However, while compartmental models adequately rep-
resent the biochemistry of well-mixed homogeneous in-vitro samples, they
are not necessarily well suited to represent micro-vascular flows and micro-
heterogeneity that are part of in-vivo tissue [Bassingthwaighte (1970), Li,
Yipintsoi and Bassingthwaighte (1997) and Ostergaard et al. (1999)]. Con-
sequently, there is interest in more flexible nonparametric approaches to the
estimation of the tissue residues. Among the most popular approaches is the
spectral method introduced by Cunningham and Jones (1993). Here residues
are approximated by nonnegative sums of exponentials, whose amplitudes
and rate constants are adapted to the data; see Veronese et al. (2013) for
a recent treatment and review. Spectral methods have the complexity of
requiring estimating of a set of intrinsically nonlinear exponential rate con-
stants. This is a significant practical computational challenge; see Zeng et al.
(2012), for example. But spectral methods also have a theoretical limitation
in that they force the negative-derivative of residue function, aka the transit
time density of tracer-atoms, to be monotonically decreasing from a mode
at zero. This assumption is at odds with micro-vascular flow measurements
which support a more log-Normal or Gamma-like form for the transit time
density. If the residue is to be estimated nonparametrically, it is desirable to
have a procedure, like that given in Hawe et al. (2012) or O’Sullivan et al.
(2009), that does not impose an unrealistic physiologic assumption on the
residue function ab initio.
Our focus here is on voxel-level estimation. The method approximates
voxel-level residues by a mixture of basis residue functions that have been
optimized by applying a backward elimination technique to a segmentation
NONPARAMETRIC RESIDUE ANALYSIS 3
of the entire volume of data. The use of mixtures in this setting is not new
[O’Sullivan (1993)], however, unlike the previous work, which has involved
approximation of mixtures of compartmental models by a compartmental
model form, the current approach does not require this step. An important
aspect of the methodology is decomposition of the tissue residue to sepa-
rately focus on characteristics associated with short transit times of tracer
atoms in the vasculature, distinct from slower transit times associated with
blood-tissue exchange and retention. This decomposition parallels the of-
ten separate consideration given to early and late life-time mortality pat-
terns in human life tables. The methodology leads to a practical quadratic
programming-based algorithm for voxel-level residue reconstruction and as-
sociated generation of functional metabolic images of parameters of interest.
For a typical dynamic PET study the analysis, including the segmentation
steps, runs on a 3.2 GHz PC in less than 30 minutes. In the context of
PET scanning in cancer applications, that is, about 90% of all clinical PET
imaging studies, this is completely adequate for routine operational use.
Section 2 presents the basic statistical models underlying the approach.
Inference and model selection methodology are developed in Section 3. Sec-
tion 4 presents illustrations with imaging data from both normal subjects
and cancer patients. Performance of the methodology for 18F fluoro-deoxy-
glucose (FDG) and 15O water (H2O) imaging studies is considered in Sec-
tion 5. This includes comparisons with compartmental model analysis and
more theoretical evaluation via simulations.
2. Theory. Let CT (t, x) represent the concentration of tracer atoms at
time t in a tissue voxel with three-dimensional spatial coordinate x. CT (t, x),
measured as activity per unit mass (mg) of tissue, evolves in response to the
localized arterial input function, denoted CP (t, x) and measured as activ-
ity per unit volume (ml) of whole blood. The basic assumption of most
PET imaging is that the interaction of the tracer with the tissue can be
approximated as a linear and time-invariant process. Thus, the measurable
concentration arises as a convolution between the tissue response and the
arterial input function
CT (t, x) =
∫ t
0
R(t− s,x)CP (s,x)ds.(1)
Here R(t, x) is tissue response and, borrowing terminology of the work of
Meier and Zierler (1954) on indicator dilutions, R(·, x) is called the residue
function. Formally, R(·, x) is proportional to the impulse response of the tis-
sue at location x and has units of flow (ml/g/min). If all tracer atoms were
instantaneously introduced in a unit volume of blood, R(·, x) would give the
number remaining in the tissue as a function of time. If N tracer atoms per
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ml are introduced in the arterial blood supply to the tissue, for small time
increments ∆t, then the number of those atoms, per gram of tissue, remain-
ing in the tissue over the time interval [t, t+∆t] is NR(·, x)∆t. In statistical
terms, R(·, x) defines the life table for the time variable which measures the
duration of stay of the tracer atom in the tissue—the transit time. Tracer
atom transit times are viewed as random—they arise from a range of inter-
actions with an array of micro-vascular flow paths, transporters, enzymes,
ligands, etc. that have the potential to influence the overall length of time
the tracer atom is in the local tissue region. Measurable transit times are
restricted to the observation window [0, Te] of the scanning and, apart from
the complexity of indirect measurement by the convolution equation, there
is censoring because tracer atoms decay over time. Such restrictions will be
familiar, as they arise in traditional life-table work.
2.1. Decomposition of residue and key summary parameters. To better
understand the residue, it is helpful to separate the early (vascular) compo-
nent from the later components that are associated with longer term inter-
action with the tissue and also retention.3 Using τv ∈ (0, Te) as a cutoff for
rapid (large-vessel) transit times, a decomposition of the residue is obtained
as
R(t, x) =RB(t, x) +RD(t, x) +RX(t, x),(2)
where RB(t, x) =R(t∧ τv, x), RD(t, x) =R(t∨ τv, x)−R(Te, x) and RX(t, x)
is the constant R(Te, x). We refer to RB as the rapid vascular component, RD
as the exchangeable or in-distribution component and RX as the (apparent)
extracted component. Apparent is used because the ultimate (asymptotic)
extraction is not strictly observable based on the finite duration of the study,
however, as it is common to choose Te large enough that there would be little
further decline in the residue at times greater than Te, R(Te, x) should be a
good approximation to the relevant flux of the tracer atoms into tissue. The
decomposition in (2) is dependent on the value of τv (and Te). For human
imaging, the choice of τv = 1 minute is reasonable, as this matches the early
vascular distribution time for intravenously injected contrast agents, upon
which the standard scanning duration used to assess local blood volume pa-
rameters in computerized tomography (CT) and magnetic resonance (MR)
is based [Provenzale et al. (2008)]. In the absence of other information, the
temporal resolution of a PET study for the residue can be no better than
the temporal sampling of scanning and the sharpness of the arterial input
resulting from the intravenous injection of the tracer.
3This is similar to how a mortality life table might be dissected to focus on survival
patterns at different stages of life.
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Each component of the residue decomposition in (2) is itself a residue or
life table. The extracted component is constant but the vascular and distri-
bution components carry information beyond scale. Key parameters for a
residue function are its maximum and integral values, which represent the
flow and volume occupied by the collection of tracer atoms defined by the
residue [Meier and Zierler (1954), Hawe et al. (2012)]. So based on the decom-
position in (2), we identify five summary parameters of particular interest—
vascular flow and volume (KB(x), VB(x)), distribution flow and volume
(KD(x), VD(x)) and the apparent flux (Ki(x)) which is seen as the net flux
of tracer into tissue up to time Te. A further parameter of interest is the ex-
traction fraction, defined by ζ(x) =Ki(x) · (KB(x) +KD(x) +Ki(x))−1. In
the case where the residue is exponential, for example, a 1-compartment
model [e.g., Bassingwaighte (1970)] with rate constants K1 and k2, for
τv = 0, the flow KD reduces to K1 and as Te →∞ the exchangeable vol-
ume VD→ K1k2 . Also, for a 2-compartment FDG model [Phelps et al. (1979)]
with k4 = 0 and τv = 0, as Te →∞ KD → K1k2k2+k3 , VD →
KD
k2+k3
and the flux
value Ki(x)→ K1k3k2+k3 .4
Substitution of the residue decomposition (2) into (1) gives a decom-
position of the tracer tissue concentration as a sum of vascular (CV ), in
distribution (CD) and extracted (CX ) components
CT (t, x) =CV (t, x) +CD(t, x) +CX(t, x).(3)
The sum CE(t, x) =CD(t, x)+CX(t, x) is the extravascular component. Ex-
amples of this are shown in Section 4. As RX is constant, CX(t, x) is the
product of flux and the cumulative arterial activity. At late time points,
vascular and exchangeable concentration are safely ignored so the late time
concentration is effectively proportional to the cumulative arterial activity.
This is the basis of a model-free approach to the analysis of flux [Patlak,
Blasberg and Fenstermacher (1983)].
2.2. Additive modeling of the tissue residue. A variety of blood-tissue
exchange models, for example, Bassingwaighte (2000), Huang and Phelps
(1986) and Gunn et al. (2002), as well as many general life-table meth-
ods, for example, Cox and Oakes (2001) and Lawless (2003), might be used
to approximate tissue residue functions. We should allow any approach that
does not systematically misrepresent the physiologic/metabolic processes in-
volved. Validation of model formulations for PET tracers is difficult. In-vitro
4Consideration of asymptotic quantities might be criticized, as it assumes the underly-
ing physiology is constant—extrapolation beyond the observation window is always fraught
with difficulty.
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studies clarify important biochemical transformations involved, but satis-
factory in-vivo validation of model assumptions related to the structure of
micro-vasculature flows and heterogeneities is not possible. The most widely
used one- and two-compartment models in PET reduce to representation of
the residue by sums of mono-exponential functions. While these models may
adequately represent the biochemistry involved, their ability to describe the
complexities of vascular transport is limited. Indeed, in the standard com-
partmental models the tracer atom transit time density is always monotoni-
cally decreasing, so the modal transit time for the nonextracted tracer is al-
ways zero. Physiologically this is difficult to justify [Bassingwaighte (1970)].
We use an additive model that approximates the local tissue residue
by a positive linear sum of a fixed set of distinct basis residue functions,
R¯1, R¯2, . . . , R¯J , that have themselves been derived from a nonparametric
analysis of time courses arising from a full segmentation of the data volume.
The model is
R(t, x)≈ α1(x)R¯1(t) +α2(x)R¯2(t) + · · ·+ αJ(x)R¯J (t),(4)
where the αj ’s are nonnegative constants. For simplicity, the basis residues
are normalized to have maximum of unity, that is, R¯j(0) = 1 for j = 1,2, . . . , J .
Assuming CP (t, x) can be described by a delayed version of a sampled arte-
rial time-course CP (t), which, in view of the temporal resolution of PET, is
reasonable, equation (4) implies
CT (t, x) = α1(x)C¯1(t−∆(x)) + α2(x)C¯2(t−∆(x)) + · · ·
(5)
+αJ(x)C¯J (t−∆(x)),
where C¯j(t) =
∫ t
0 R¯j(t−s)CP (s)ds for j = 1,2, . . . , J . For known delay, ∆(x),
the model is linear in the α-coefficients. Note estimation of the α’s in (5)
allows the local residues to be determined by equation (4); from them asso-
ciated flow and volume parameters of Section 2.1 can be recovered.
Remarks. 1. If the C¯j ’s in (5) correspond to specific regional time courses,
a mixture model interpretation for the model can be developed. This is rea-
sonable, as the population of available metabolic pathways for a tracer atom
is determined by the profile of enzymes, receptor ligands or transporters
that are represented. Across a collection of voxels these profiles vary with a
greater representation of certain characteristics in some voxels than in oth-
ers. Thus, the transit time for a randomly chosen tracer atom in voxel x can
be expected to select a metabolic pathway in accordance with the distribu-
tion of pathways available within the voxel, and the α-coefficients (scaled to
sum to unity) could be viewed as a set of mixing proportions; see O’Sullivan
(1993, 2006). The form in equation (4) can also be viewed as an example of
a general multivariate factor analysis (without reference to residues). Such
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models have been used to describe PET time-course data; see, for example,
Kassinen et al. (2005), Layfield and Venegas (2005), Lee et al. (2005) and
Zhou et al. (2002).
2. A tissue region can contain significant nonarterial blood vessels. De-
pending on tissue location, separate signals associated with major blood
pools in the circulatory system, such as the right ventricle of the heart,
the lungs, venous blood and the venous supply path from the injection site
to the heart, might need to be considered. This can be accomplished by
augmenting equation (5) to include terms representing nonarterial blood
signals. Obviously this is particularly relevant in the thoracic imaging where
the direct or indirect (via a spillover artifact) impact of nonarterial cardiac
and pulmonary blood signals can be significant. Venous blood vessels arise
throughout the body, so there is a case for always including a venous signal
term. But rarely does the simultaneous measurement of arterial and venous
blood activity arise in a PET study. Venous blood can be viewed as a re-
sponse to the arterial supply, so the venous signal is sensibly represented as a
whole-body response to the arterial supply—CV (t) =
∫ t
0 RV (t− s)CP (s)ds.
Thus, if an explicit venous signal is not available, the structure of our mod-
eling approach allows for the component Rj -residues to adapt to RV so that
the overall tissue residue will have the venous component included. As mean
transit times from arterial to venous blood are short (<1 minute), our pro-
posed decomposition of the residue with τb < 1 will be a combination of pure
arterial, venous contributions. Hence, VB(x) should be viewed as an estimate
of the volume (per mg) of large arterial and large venous vessels in the tissue.
Thus, if an explicit venous blood signal is included (α0(x)CV (t−∆(x))), the
local estimate of blood volume should be the sum of the venous volume [i.e.,
α0(x)] and VB(x) from the estimated residue in (2).
3. Due to limited resolution, voxel-level data are subject to mixing and
partial volume effects, which are reasonably modeled by mixtures; see also
Section 3.3.
3. Inference techniques. The estimation of voxel-level residues involves
three steps. First, a segmentation procedure is applied to extract scaled
time-course patterns from the measured set of voxel-level time courses in
the data. Next, the time courses are analyzed to recover a nonparametric
residue function for each and a backward elimination procedure is used to
obtain a reduced set of basis residue functions. The final step does voxel-
level optimization of α-coefficients and delay in equation (5) with subsequent
evaluation of the voxel residue in equation (4) and the key parameters iden-
tified in Section 2.1. The details involved in each of these steps are presented
below. As the analysis is based on a voxel-level fitting process, the residu-
als associated with the fitting process provide useful diagnostic information.
Some proposals for examining the temporal and spatial patterns in those
residuals are indicated.
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3.1. Segmentation. A split-and-merge segmentation procedure from
O’Sullivan (2006) is used. The procedure groups voxels on the basis of the
shape of the measured time course, the scaled time course. The splitting
employs a principal component analysis to recursively divide the tissue vol-
ume into a large collection (typically 10,000) of hyper-rectangular regions
whose scaled time-course patterns show maximal homogeneity. The merging
process then recursively combines (initially with a constraint to ensure that
segments consist of contiguous collections of voxels) these regions to create
a collection of regions with high average within-region homogeneity. For the
analyses reported here, the number of segments used is taken to be large
enough to explain 95% of the variance in the scaled time-course data, about
7–12 segments for a typical cerebral study and 15–20 segments for a chest
or abdominal study. The choice of the number of segments was examined
in O’Sullivan (2006). As the focus of the algorithm is on scaled time-course
information, the extracted segments are well suited for use in subsequent
mixture modeling. A particular advantage of the scaled approach is that it
results in fewer segments than might otherwise be required to explain a com-
parable proportion of variance in the data. It is helpful to display segments
to connect with anatomy. If the average scaled time course for a segment
is given by a vector µ, imaging the µ-weighted average of the voxel-level
time-course data in the segment is effective. Some examples are shown in
Section 4.
3.2. Construction of basis residues. The time bins of data acquisition are
[t
¯
b, t¯b) for b= 1,2, . . . ,B. The segmentation algorithm provides a mean time
course and associated sample variance vector, {(ykb, vkb) for b= 1,2, . . . ,B},
for each of k = 1,2, . . . ,K segments. Arising from the underlying Poisson
emissions that are the basis of the imaging process, regional time-course
data have an approximate quasi-Poisson structure [see Huesman (1984);
Carson et al. (1993) and Hawe et al. (2012)], that is,
E(ykb) = µkb and V(ykb)≈ φkµkb(6)
for φk > 1. Thus, up to known calibration factors (incorporating time-bin
duration and voxel dimension), the mean values are proportional to the
integrated concentration per milligram of radioactive tracer atoms which in
turn is a function of the regional residue Rk and input arterial supply:
µkb =
∫ t¯b
tb
Ck(t)e
−λt dt and Ck(t) =
∫ t
0
Rk(t− s)CP (s−∆k)ds,(7)
where λ represents isotope decay and ∆k is an appropriate delay. Note Ck(t)
here represents the total (radioactive and nonradioactive) tracer atom con-
centration at time t. An initial set of possible residue basis elements are
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obtained by representation of the Rk’s in terms of B-splines [O’Sullivan et
al. (2009)]. Here the B-spline coefficients and the delay ∆k are optimized by
weighted least squares with weights ̟kb given by v
−1
kb .
We seek to express the segment residues in terms of a reduced set of
basis residue forms. Since retention is apparent in nearly all residues, it
makes sense to ensure that the constant residue function (a Patlak term, cf.
Section 2.1) is a fixed member of any basis. Thus, the focus of the basis search
is on representation of the nonretained residue components. Suppose we have
a set of J − 1 such normalized basis elements denoted R¯j for j = 1,2 . . . , J −
1 as well as the constant unit value Patlak residue, R¯J . With these, the
residue for the kth segment (Rk) is approximated by the (nonnegative) linear
combination
Rk ≈ β1R¯1 + β2R¯2 + · · ·+ βJ R¯J .(8)
By substitution into (8), the β-coefficients and delay can be optimized to the
observed segment data. A weighted least squares fitting is used with weights
given by ̟kb. An approximate unbiased risk assessment criterion is used to
obtain an overall assessment of the J -component basis. The target loss is
the weighted square error difference between the true segment mean vectors
and their estimated values based on the J -component approximation
L(J) =
∑
kb
̟kb[µkb − µˆ(J)kb ]2.(9)
With zkb =
√
̟kbykb and zˆkb =
√
̟kbµˆ
(J)
kb ,
z′kzˆ
(J)
k =
∑
b
̟kbykbµˆ
(J)
kb =
∑
b
̟kbµkbµˆ
(J)
kb +
∑
b
̟kb(ykb − µkb)µˆ(J)kb .
So in the case that the vector µˆ
(J)
k is a linear function of the weighted data,
that is, zˆ
(J)
k =HJzk, E(z
′
kzˆ
(J)
k ) = µ
′
kE(zˆ
(J)
k ) + trace[HJΣk], where Σk is the
covariance of zk. But separate time frames, which involve distinct emission
events, are statistically independent, so Σk is diagonal. From equation (7),
the diagonal entries of Σk are approximately φ̟kbµkb for b = 1,2, . . . ,B.
Letting Dˆk be the diagonal matrix with entries ̟kbykb, we are led to the
criterion
C(J) =
∑
k
{∑
b
̟kb[ykb− µˆ(J)kb ]2 + 2φk trace(HJDˆk)
}
for evaluation of the loss L(J) in equation (9). Since EC(J) = E(L(J)) +
φ
∑
kb̟kbµkb, up to a constant that is independent of J , C(J) is an un-
biased estimator for L(J). With φk = 1, this statistic has a close connec-
tion to the Rudemo and Bowman cross-validation statistic for density es-
timation; see, for example, O’Sullivan and Pawitan (1996) who gave a cor-
responding risk estimator for bandwidth selection in Poisson deconvolu-
tion problems. For practical use a choice of φk must be made—the ratio
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φˆk =
∑
b vkb/
∑
b ykb seems reasonable for this. If HJ is a projection, that
is, µˆ
(J)
k is approximately obtained by a weighted least squares regression,
trace(HJ) = J and trace(HJDˆk) might reasonably be approximated as Jd¯k,
where d¯k =
1
B
∑
b̟kbykb. Thus, we obtain a criterion with a familiar AIC-like
[Akaike (1974)] form5
Cˆ(J) =
∑
k
{∑
b
̟kb[ykb− µˆ(J)kb ]2 +2φˆkd¯kJ
}
.(10)
Using this criterion, a backward elimination procedure is used to select a
subset of the starting K + 1 basis residues (corresponding to the segment
data residue fits plus the Patlak residue). The resulting basis set is applied
in the analysis of voxel-level data.
3.3. Voxel-level optimization and local averaging. At the voxel-level we
have data with substantially the same structure as the segment-level data,
ybk above. If ybi for b= 1,2, . . . ,B is the PET measured activity at the ith
voxel, from equations (6) and (7) we have E(yib) = µib and V(yib) = φiµib
with
µib = αi1µ¯1b(∆i) +αi2µ¯2b(∆i) + · · ·+αiJ µ¯Jb(∆i)≡ µ¯b(∆i)′αi,(11)
where αij = αj(xi), and with C¯j(t) =
∫ t
0 R¯j(t−s)CP (s)ds, µ¯jb(∆i) =
∫ t¯b
tb
C¯j(t−
∆i)e
−λt dt. This is in the form of a quasi-Poisson regression problem [Mc-
Cullagh and Nelder (1983)]. A standard iteratively reweighted least squares
method is used for optimization of unknowns. With weights defined by the
current guess, ωib = 1/µ
(0)
ib , updated values for the unknowns are obtained
by minimization of
WRSS(αi,∆i) =
B∑
b=1
ωib[yib − µ¯b(∆i)′αi]2(12)
with positivity constraints on the α-coefficients. Thus, for fixed ∆i, fast
(exact) quadratic programming codes are used for evaluation of solutions,
making the computation efficient. Grid search is used for optimization of the
delay. The impact of iterative reweighting on computing time here is quite
minimal: Typically the solutions obtained with a fixed set of weights, such
as weights which are inversely proportional to the segment variance (vkb, if
the voxel belongs to segment k), produce results that are largely unaffected
by subsequent iteration.
5It should be clear that this is not in fact an information criterion in the formal sense—
only first and second order moment assumptions are involved.
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Local averaging and smoothing. The residue formulation allows residues
for locally averaged (smoothed) data to be evaluated as local averages of
residue coefficients—if local variation in delay is negligible. To see this, sup-
pose wxi for i= 1,2, . . . ,N represents a set of nonnegative weighting coeffi-
cients used to produce the averaged data—y˜xb =
∑
iwxiyib is the averaged
data at voxel x. Assume that the weights are focused, in the sense that
wxi > 0 for i in a neighborhood Nx and the delay variation is negligible
here, that is, ∆i ≈∆ for i ∈ Nx. Let µib = µ¯b(∆)′αi for i ∈Nx. From (11)
we have
µ˜xb =
∑
i
wxiµib
(13)
= α˜x1µ¯1b(∆) + α˜x2µ¯2b(∆) + · · ·+ α˜xJ µ¯Jb(∆) = µ¯b(∆)′α˜x,
where α˜xj =
∑
iwxiαij . Thus, the mean of the smoothed data y˜xb is given
by a positive linear combination of the basis elements µ¯jb(∆) in (11). Using
(11) again, we can also write µ˜xb =
∫ t¯b
tb
C˜x(t − ∆i)e−λt dt, where C˜x(t) =∫ t
0 R˜x(t− s)CP (s−∆)ds and
R˜x(t) = α˜x1R¯1(t) + α˜x2R¯2(t) + · · ·+ α˜xJ R¯J(t).(14)
Hence, the averaged α-coefficients define the appropriate local residues for
the averaged image data. This result has implication for smoothing by local
averaging methods. While data smoothing/filtering is not the only mecha-
nism used to achieve regularity in statistical function estimation, it is widely
used and very reasonable in many image processing contexts, including to-
mography [Natterer and Wu¨bbeling (2001)]. The parametric images pro-
duced in the examples in Section 4 are subjected smoothed—the computed
α-coefficients are convolved with a 3-D Gaussian kernel whose coordinate
standard deviation is between 1 and 2 times the voxel dimension.
3.4. Diagnostic evaluation of model adequacy. To ensure the validity of
the parametric imaging results, we assess the assumptions underlying the
fitted parametric model by examining the temporal and spatial patterns in
the voxel-level standardized residuals:
rib =
√
wib · [yib − yˆib],(15)
where wib = yˆ
−1
ib . Both temporal and spatial patterns in these residuals
should be examined. Temporal aspects are best appreciated by plotting
uptake data, for example, time courses for segments together with fitted
modeling results. The spatial distribution of the residuals can be exam-
ined but the standardization by activity is unstable for low activities (recall
that the raw filtered back-projection reconstructed data can be negative for
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some voxels). Thus, we find it best to use a common set of weights wib = w¯b
and compare the spatial pattern of the residual and data root mean square
(RMS):
RMS(residual) =
√∑
b
w¯b[yib − yˆib]2/B;
RMS(data) =
√∑
b
w¯b[yib − y¯i]2/B,
where y¯i is the weighted mean of the time course. Techniques for analysis of
temporal and spatial patterns in residuals are needed, such as estimation of
their spatial covariance structure, which might be related to the PET image
reconstruction process [Carson et al. (1993), Maitra and O’Sullivan (1998)].
4. Application to real data. We now present some case studies to illus-
trate the parametric imaging technique. The first examples come from cere-
bral imaging in normal subjects using the two most well-established PET
tracers, FDG and H2O. The second set of examples are from imaging cancer
patients using FDG and H2O as well more experimental tracers. All studies
were carried out on a GE Advance PET scanner at the University of Wash-
ington. This scanner produces reconstructions of tracer uptake (per time
bin of acquisition) as an array consisting of 35 transverse planes/slices and
a within-slice discretization of 128× 128 voxels. Slices have a fixed thickness
of 4.25 mm, but the within-slice voxel resolution can be varied depending
on the tissue volume in the field of view, typically 2.23 mm for brain studies
to 4.29 mm for abdominal and thoracic studies. The scanner does not use
X-ray CT acquisition for attenuation measurement. Instead attenuation is
derived from PET transmission scans with a 511 keV rod source. All data
were reconstructed using standard filtered back-projection methods. Below
we present uptake and parametric images superimposed on images of PET-
measured attenuation. Tracers were injected intravenously and catheterized
sampling used to measure the tracer time course in the arterial blood (CP ).
4.1. Brain studies in normal subjects with FDG and H2O. The FDG
data set is a series reported in Graham et al. (2002). For FDG, dynamic
PET imaging was carried out over a 90-minute time period (Te = 90). The
tracer dose (370 MBq) was injected over a 1-minute period, and B = 31 time
frames of data were acquired according to the following sampling: 1 minute
pre-injection frame followed by 4 15-second frames, 4 30-second frames, 4
1-minute frames, 4 3-minute frames and ending with 14 5-minute frames.
A 10-region segmentation of the data was used to initialize the mixture
model analysis, that is, K = 10 in Section 3.2. This segmentation explained
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over 95% of the variance in the data. Initialization with 20 or 40 segments
produced little or no change in results. The final mixture model and associ-
ated normalized basis residues (apart from the constant residue component)
had 3 components; see Figure 1(a). Figure 1(a) shows total tracer uptake
as well as computed values of the flux (Ki) and distribution volume (VD);
cf. Section 2.1, superimposed on the PET-measured tissue attenuation. The
flux is the most well-resolved parameter here, showing high values in white
and gray matter structures of the brain. Distribution volume shows a more
diffuse pattern with elevated values outside the brain (cf. the nasal cav-
ity). In all cases the values of metabolic parameters are in agreement with
values reported in the literature; cf. Graham et al. (2002). Overall, the ki-
netic analysis of flux and volume of distribution provides an understanding
of tissue metabolism of FDG that cannot be appreciated from the uptake
information.
The H2O data come from a series reported in Muzi et al. (2009). The
tracer dose (776 MBq) was injected over a 5-second time period. Dynamic
PET imaging was carried out over a 7.9-minute time period (Te = 7.9).
A set of B = 42 time frames of data was acquired according to the following
sampling: 1-minute pre-injection frame followed by 5 3-second frames, 10
6-second frames, 12 10-second frames, 8 15-second frames and ending with 6
20-second frames. Similar to FDG, a 10-region segmentation of the data was
used to initialize the mixture model analysis, that is, K = 10 in Section 3.2
(values of K = 20 and K = 40 were also considered but produced little or
no change in results). The mixture model and associated normalized basis
residues, apart from the constant residue component, had 4 components;
see Figure 1(b). Figure 1(b) shows total tracer uptake as well as computed
values for vascular blood volume (VB) and the distributional flow component
(KD). Note the vascular blood volume is elevated in the neighborhood of
the internal carodits and the nasal cavity. The (distributional) flow pattern
is elevated in the white and gray matter structures of the brain. In general,
values of metabolic parameters are in agreement with those reported in the
literature; cf. Muzi et al. (2009). Similar to FDG, the kinetic analysis here
is seen to add to the information provided by uptake alone.
Figure 2 presents some diagnostic information for the analyses presented.
Sample segments and the results of the associated nonparametric residue
analysis are shown. The increased variability of H2O is evident. Even though
the injected dose is larger than that of FDG, the shorter time frames and
much shorter half-life of 15O results in lower radioactivity per time frame in
the H2O study. Consequently, the data have more noise, as reflected in the
displayed parameters. The voxel-level residual RMS characteristics of the fit
are shown in Figure 2. For FDG, the RMS error is very small relative to the
tracer uptake; in the case of H2O, the RMS error is generally higher relative
to uptake, but there still does not appear to be a spatially coherent structure
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(a) Dynamic 90-minute PET-FDG study in a normal subject
(b) Dynamic 7.5-minute PET-H2O study in a normal subject
Fig. 1. Color maps of selected kinetic parameters (cf. Section 2.1) recovered by residue
analysis and the integrated uptake divided by study duration. Transverse, sagittal and coro-
nal slices shown. The gray-scale images give tissue attenuation measured by the PET trans-
mission scan. Line plots give the fitted mixture model [cf. C¯j in equation (6)], including the
arterial input (CP in red) and the Patlak component (blue). The normalized, non-Patlak,
basis residues [R¯j in equation (5)] are also shown on the right.
to the lack of fit. The fitted residue models for the selected segments are in
good agreement with the data; see Figure 2. The decomposition of the time
course of the fitted models show the vascular and nonvascular components
of the fit [cf. equation (3)]. Note the time courses with high vascular contri-
butions arise from well-known blood pools in the neck and nas
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Fig. 2. Top: Sample segment time-course data (points) and fitted step-function non-
parametric residues (gray). The fitted residue-model time course (black line) is shown
with vascular (purple) vs. nonvascular (brown) components: CV and CE after (3). Inserts
show the intensity of the time course within the region of the segment. Right color maps
show the distribution of the RMS for data and residuals from analysis (cf. Section 3.4).
Bottom: (Left) Raw piecewise constant residues for segments (scaled to unity). A den-
drogram obtained by clustering residues is also provided. (Center) Line plots are scaled
B-spline-computed residues without retention [R¯j ’s in (9)]. (Right) Risk values [Cˆ(J) in
(10)] plotted against the number of components (J) in the mixture model—optimal number
shown with blue line.
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vascular signals arise from white and grey matter tissue. The full set of fit-
ted piecewise constant nonparametric residues [Hawe et al. (2012)] as well as
the smoother residues produced by B-spline fitting [O’Sullivan et al. (2009)]
are also shown in Figure 2. Note these latter residue curves only present
the nonretained parts of the residues, that is, extraction is subtracted. The
model selection criterion is plotted against the number of retained compo-
nents. Three components are indicated for the FDG and four for the H2O
data. A dendrogram for a hierarchical cluster analysis of the raw residues
(normalized and adjusted for extraction) using a Euclidean distance matrix
shows some exploratory support for the number of components selected.
Note that, unlike the model selection statistic, the cluster analysis does not
involve any recursive refitting of the time-course data. Overall, the analysis
and diagnostics are very reasonable. A more detailed analysis over a series
of similar cerebral studies is provided in the next section.
4.2. Cancer imaging examples. The use of PET for metabolic imaging
of cancer and its response to therapy is of current clinical interest [Aboagye
(2010), Krohn et al. (2007) and Mankoff et al. (2007)]. While PET-FDG
imaging is an indicator of glucose metabolism, other aspects of cancer biol-
ogy may also be useful. Cell proliferation, hypoxia, vascularity, drug resis-
tance and cell death play important roles and the study of these processes in
cancers with PET radiotracers is being explored with clinical imaging trails
[Krohn et al. (2007)]. We present two examples to illustrate applications of
our metabolic imaging procedure in such contexts. From a methodological
viewpoint, these examples demonstrate the versatility of the residue imaging
technique across a range of radiotracers and also in different target tissue
volumes.
I. Brain tumor study. These data are from a series in Spence et al.
(2009). The patient is a 39-year-old with recurrent right parietal anaplas-
tic astrocytoma. The patient had follow-up clinical MR scans at 4 and 4.5
years after initial treatment with a combination of surgery, radiotherapy and
chemotherapy. At the time of follow-up PET scans with 11C-labeled acetate
(ACE), 11C-labeled carbon dioxide (CO2) and 18F-labeled fluoro-thymidine
(FLT) were carried out. The ACE and CO2 studies were performed at the
4-year follow-up and the FLT at the 4.5-year follow-up. The focus of these
PET scans was to study the potential for differentiation between tumor re-
gional radionecrosis (residual but dead tissue) from tumor recurrence. This
issue is difficult to decide on the basis of the standard clinical MR scan.
Acetate flux is an indicator of membrane lipid synthesis [Yu et al. (2011)]
and so may provide an early indicator of tumor recurrence. Metabolism of
acetate produces carbon dioxide. As a result, the interpretation of acetate
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is somewhat confounded by processes associated with the fate of 11C in car-
bon dioxide. The CO2 PET study is used to address this issue. FLT has the
potential to provide information on the rate of thymidine utilization and
this in turn is a potential indicator of cell proliferation.
Tracers were introduced by 1-minute intravenous infusion. The sampling
protocols for ACE and CO2 were identical: Frame durations in seconds
(some of which were repeated a number of times) were as follows: 5(18),
10(7), 20(4), 60(4), 180(4), 300(8) for a total of B = 45 dynamic scans. With
FLT there were B = 47 frames: 10(10), 20(4), 40(3), 60(3), 120(5), 180(4),
300(18). An initial K = 10 region segmentation was used for each data set.
The selected mixture models have 5, 3 and 4 terms for ACE, CO2 and FLT.
In each case, temporal and spatial diagnostics for the mixture model fit were
satisfactory. Results of metabolic parameters are shown in Figure 3(a). The
tumor region is apparent on both magnetic resonance (MR) scans. ACE
flux is elevated in parts of this and these areas are also seen as high FLT
flux. The CO2 flux is elevated in the brain ventricle/choroid plexus. The
choroid plexus makes cerebral spinal fluid (CSF) in part by carbonic anhy-
drase to facilitate the exchange between CO2 and water and bicarbonate,
and this starts in the cerebral ventricles. Thus, it makes physiologic sense
that choroid plexus has high CO2 flux. There is an increased flow of FLT
in the skull bone marrow and that is also elevated (perhaps as a result of
blood-brain-barrier disruption) in the tumor. Note that the FLT flux is not
substantially elevated in the marrow of the skull here. In normal circum-
stances this would be unexpected, however, because the marrow is lower on
the side of the tumor, compared to the other side, this is likely a radiation
effect. The increased FLT flux in the tumor region abnormality suggests en-
hanced cellular proliferation—possible tumor recurrence. The Spence et al.
(2009) report found that FLT flux has potential as an imaging biomarker
for distinguishing proliferation in patients with recurrent gliomas from ra-
dionecrosis, which has a similar MR pattern. There are a number of National
Cancer Institute (NCI) sponsored trials underway that are investigating the
potential of PET-FLT for guiding the treatment of cancer patients. The
quantitation of flux and flow provided here enhances the understanding of
the information provided by these studies.
II. Breast cancer. This data here is from a series of locally advanced
breast cancer patients studied with PET FDG and H2O prior to treatment
with neoadjuvant chemotherapy. The study, reported by Dunnwald et al.
(2008), showed that the mismatch between H2O evaluated flow and FDG
measured flux, provided a prognostic indicator of response and disease-free
survival. A bolus intravenous injection of H2O was followed by dynamic
PET image acquisition over a 7.75 minute period. A total of B = 53 frames
were obtained. A 1-minute pre-injection scan was followed by consecutive
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(a) Brain tumor
(b) Breast cancer
Fig. 3. (a) Brain tumor 4 and 4.5 years after treatment. Standard clinical T1-weighted
Magnetic Resonance images—tumor site indicated with pink arrow. Dynamic PET imaging
with 11C Acetate and 11C CO2 at 4-year follow-up were analyzed by residue analysis to
obtain flux estimates. Dynamic 18F fluoro-thymidine PET imaging was analyzed by residue
analysis to obtain flux, Kd and Kb estimates. Transverse images through a representative
plane of the tumor are shown. (b) Patient with locally advanced Breast Cancer imaged
with PET-H2O and PET-FDG. Transverse slices of tracer uptake and residue calculated
metabolic images of blood and distribution volume and flux. The grey scale is the measured
tissue attenuation. The tumor site indicated with pink arrows.
frames whose durations in seconds (with number of repeats) were as follows:
2(15), 5(14), 10(10), 15(8), 20(5). A short time later the FDG study was car-
ried out. This entailed 2-minute intravenous infusion of FDG. A 1-minute
pre-injection scan was followed by 24 further frames; these frame durations
in seconds (including repeat number) were as follows: 20(4), 40(4), 60(4),
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180(4), 300(4). There was no blood sampling, but analysis of the right ven-
tricle of the heart region was used to extract an arterial input function in
the analysis. Additional time courses for venous blood (vena-cava), the pul-
monary veins and the right ventricle of the heart were also recovered from
the PET image data; see Huang and O’Sullivan (2014) for details of the
technique used. These signals were included as additional terms in the seg-
mentation and mixture model analysis. In view of the increased range of
tissue structures in the field of view, a greater number of segments (K = 15)
were used. Selected mixture models had 5 residue components for FDG and
4 for H2O. In each case temporal and spatial diagnostics for the mixture
model fit were satisfactory. Parametric images are shown in Figure 3(b).
The raw uptake patterns for the tracers do not differentiate between ar-
eas with high vascular uptake (heart cavity, liver) and areas with increased
longer term retention (tumor and heart wall). The vascular and retention
patterns are well described by images of blood volume (VB), distributional
flow (KD) and flux (Ki). The increased apparent retention time of water
in the tumor region (seen as a “flux” in the water residue analysis) may
reflect that less effective vasculature often is associated with cancers, par-
ticular larger cancers; see Dunnwald et al. (2008) and Jain (2005). This is
an example of a patient whose tumor has low blood flow and high FDG up-
take, which is nicely captured by the analysis. The greatest FDG flux is in
the section of the tumor at the edge of an apparent necrotic section, which
makes sense as a place where blood flow would be low and FDG uptake
might be high. We expect the flow measures to be similar from water and
FDG [Tseng et al. (2004)], and the images support this.
5. Analysis of performance. We consider cerebral PET studies with FDG
and H2O and examine aspects of the proposed methodology using both real
and simulated data. One issue is to determine how regional averages of voxel-
level residue estimates compare to regional residue estimates produced by
analysis of regionally averaged time-course data. The latter issue is of inter-
est because it is the common way that regional summaries of PET tracer
kinetics are obtained. We used numerical simulations to explore this mat-
ter. A second issue is whether the approximation capabilities of our residue
basis are adequate for real data. Recall the underlying mixture model is con-
structed adaptively by segmentation of the entire image volume. It is not
clear if the derived mixture basis set has adequate local approximation char-
acteristics. We compare our mixture modeling approach with an analysis of
regionally averaged time-course data using standard compartment models.
5.1. Adaptive mixtures versus compartmental model residues. As previ-
ously indicated, the sample data sets used in Section 4.1 are taken from two
series on normal subjects reported by Muzi et al. (2009) and Graham et al.
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(2002). In those series PET time-course data for a number of brain struc-
tures were recovered. With detailed reliance on co-registered high-resolution
MR scans for anatomic reference, region of interest (ROI) PET time-course
data for a number of brain structures were created. For FDG there were
10 regions in each of 12 studies to give a total of 120 ROI data sets. The
regions were as follows: cerebellum, temporal, frontal, parietal and occipi-
tal cortex, thalamus, putamen, caudate, whole brain and white matter. For
H2O, a set of 11 subjects was considered with each subject scanned twice.
In each study between 6 and 9 regions were considered, giving a total of 184
ROI data sets. The regions included: choroid, pituitary and salivary gland,
ventricle, selected whole brain regions, white and gray matter. In Muzi et
al. (2009) and Graham et al. (2002), these ROI data were analyzed using
the conventional compartmental models.6 Here we compare compartmental
analysis of these H2O and FDG ROI data with analysis obtained using the
adaptive mixture model recovered using the segmentation and recursive re-
finement algorithm of Section 3.1 and Section 3.2 of this paper. The mixture
model was then applied to analyze the time-course data for each of the ROIs
that had been recovered in the study, that is, application of the model in
equation (11) to the ROI data. At the same time the ROI data were also ana-
lyzed using the relevant compartmental models. For reference, the ROI data
were also analyzed using a fully nonparametric procedure with a piecewise
constant residue [Hawe et al. (2012)]. In terms of fit, this gives an effective
lower bound on what can be achieved for a given data set. Leave-out-one
cross-validation residuals [Weisberg (1985)] were constructed for each anal-
ysis method, and the weighted sums of squares of these residuals were used
for comparisons between different methods. Absolute cross-validated residu-
als from the mixture and compartmental approaches were also subjected to
a paired Wilcoxon test [Wilcoxon (1945)]. The p-value for this test provides
evidence against the hypothesis of similarity between the average magnitude
of cross-validated residuals from the compartmental and mixture analysis.
An overall comparison between the compartmental and mixture models is
also carried out. A sign test is applied to the set of differences between the
cross-validated residual sums of squares for the mixture and compartmental
model. The mixture model is favored if the percentage of time it outperforms
the compartmental model is significantly greater than 50%. We also compare
compartmental and mixture model-based estimates of key kinetic parame-
ters: flux (Ki) and distribution volume (VD) for FDG and blood volume (VB)
and the distributional flow (KD) for H2O. Note in the compartmental case
this involves evaluating the fitted compartmental residue and then using the
definitions in Section 2.1 to evaluate the resultant kinetic parameters.
6A description of the relevant 1- and 2-compartmental models used for H2O and FDG
in a normal brain can be found, for example, in Huang and Phelps (1986).
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(a) FDG data
Fig. 4. Comparison between selected kinetic parameters recovered from analysis of ROI
data using compartmental (FDG and H2O) and mixture models (1,2,3). 4. Sample ROI
data (dots) together with fitted compartment, mixture and nonparametric analysis (red, blue
and grey lines); fitted residues are shown with broken lines. 5. Color-coded leave-out-one
cross-validated residuals. 6. Histogram and cumulative distribution (dots) of Wilcoxon
p-values for paired comparison of the absolute CV-residuals of the compartmental and
mixture models, line of identity included.
Results are presented in Figure 4. With FDG, the cross-validated resid-
ual sum of squares for the adaptive mixture models is lower than that for
the 2-compartment model in 97 of the 120 ROIs examined (80% of cases).
This is highly significant. In addition, the distribution of Wilcoxon p-values
clearly favor the mixture model; see Figure 4(a)6. Results for H2O are not
as strong. Here the adaptive mixture models is lower than that for the 1-
compartmental model in 137 of the 184 ROIs examined (74% of cases). This
is again highly significant. However, the distribution of Wilcoxon p-values
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(b) H2O data
Fig. 4. (Continued).
[Figure 4(b)6], while still favoring the mixture model, is more uniform than
was found for FDG. This reduced improvement in the mixture model is
very likely a reflection of the higher noise which is evident in many of the
H2O ROIs. Some representative sample time-course data and the models fit
are also shown in Figures 4(a)4 and 4(b)4. In the high noise H2O exam-
ple, the improvement in fit achieved by the mixture model is not so clear,
however, there is little ambiguity in the FDG case. Figure 4 also reports
comparisons between kinetic parameters recovered using the mixture and
compartmental model analyses. Note the kinetics from the compartmental
and mixture analysis are quite similar, particularly with flux and volume of
distribution in FDG Figure 4(a)1–2. Discrepancies in flow values are appar-
ent in Figure 4(a)3, with higher flow values being produced by the mixture
analysis model. Somewhat noisier patterns are found with H2O. Flow and
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blood volume values obtained by the mixture analysis are on average higher
than those of the compartmental model analysis; see Figure 4(b)1–3. The
1-compartmental model produces somewhat higher distribution volume val-
ues; see Figure 4(b)2. Given the model fit comparisons, parameters provided
by mixture analysis are likely to be more reliable for FDG and H2O.
5.2. Simulation study. A prime motivation for mapping of residues at
the voxel level is the simplicity with which the residue for a region can then
be obtained, that is, by simply averaging the voxel-level residue estimates.
If voxel-level data were measured without error, this approach would be
guaranteed to yield the correct regional residue. However, one might have
concern that with realistic noise, estimation at the voxel-level might be so
poorly behaved that the regional averaging of voxel-level estimates would
not produce good estimates of the target regional values. Here the residue
recovered from analysis of the average time course for the region might be
more accurate. We explore this issue in the context of the brain studies
analyzed in Section 4.1. Recall those analyses involved consideration of K =
10 segments, each with a characteristic time course: yk for k = 1,2, . . . ,K.
Each time course was subsequently represented as a linear combination of a
reduced set of (J) basis residues as described in equations (4) and (5)—and
modeled, similar to equation (11), as
ykb = µkb +w
−1/2
kb εkb,
where µkb =
∑J
j=1αjkµ¯jb(∆k), wkb = 1/µkb and the errors εkb are found
to be approximately Guassian with mean zero and constant variance, say,
φ2k. Given that these data are from normal subjects, the configuration of
the coefficients α·k = (α1k, α2k, . . . , αJk) for the K segments is realistic for
normal cerebral PET studies with the FDG and H2O tracers. We bootstrap
from these results to simulate voxel-level data for a set ofK synthetic regions
of interest (ROIs).
The simulated data for the ith voxel in the kth region is generated by
ykib = µ˜kib+ w˜
−1/2
kib ε˜kib(16)
for i = 1,2, . . . ,Nk and b = 1,2, . . . ,B. Here µ˜kib =
∑J
j=1 α˜ijkµ¯jb(∆˜ik) and
w˜kib = 1/µ˜kib, with ε˜kib, ∆˜ik and α˜ijk independent random variables. The
measurement errors (ε˜kib’s) are mean zero Gaussian with variance Nkφ
2
k for
i= 1,2, . . . ,Nk. Amplification of the variance by Nk ensures the mean error
over voxels has variance φ2k; the delays (∆˜ik’s) are log-normal with mean ∆k
and standard deviation proportional to the size of the region. The coefficient
of variation is 20% in the largest region and, finally, the residue basis scales
(α˜ijk’s) are generated from a Gamma distribution with mean αjk and coef-
ficient of variation set in proportion to the region size. The largest region
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has a coefficient of variation of 20%. This structure is designed to capture
the intra-region voxel-to-voxel variation in terms of the time-of-arrival of
the tracer, the voxel-to-voxel variation/heterogeneity in residues (including
flow) and, of course, the quasi-Poisson measurement errors associated with
PET instrumentation [Carson et al. (1993) and Huesman (1984)]. The over-
all scale of α-coefficients is varied to achieve a range of six activity levels,
equispaced on a logarithmic scale, the highest of which is 20 times larger
than the lowest activity. The 10 regions had sizes (Nk) as follows: 20, 22,
39, 73, 85, 92, 93, 287, 345 and 1519 for FDG; 20, 31, 42, 128, 173, 195, 213,
394, 399 and 925 for H2O.
Sample voxel-level and mean ROI time-course data are shown in Figures
5(a)1–3 (FDG) and 5(b)1–3 (H2O). The intermediate activity/noise data
are qualitatively similar to the data in Section 4.1. Sample residue estimates
at the voxel and ROI levels are also shown in these same figures. Regional
residues were computed in 2-ways, one based on analysis of the mean time-
course data for the region and the other involving averaging of voxel-level
residues. Voxel-level analysis could be done with and without imposition
of positivity constraints on α-coefficients. In high-noise environments, con-
strained estimators will be biased. The averaging of such estimators rein-
forces the voxel-level bias leading to a bias in the regional summary. In light
of this, for quantitative regional analysis, the averaging of unconstrained
voxel-level residues is recommended [Huang et al. (2013)].
Simulations involving data generation for 6 noise levels and 10 regions
were repeated 50 times. Estimated residues were compared to true values
directly using the integrated squared deviation and also in terms of squared
deviation of key parameters, flux and distribution volume for FDG and
flow and volume of distribution for H2O. The squared deviations were aver-
aged over replicates to obtain estimates of mean square errors (MSE). The
MSE for the averaged voxel-level estimators are plotted against dose in Fig-
ure 5(a)4–6 (FDG) and Figure 5(b)4–6 (H2O). A very similar pattern is
found for the MSEs estimators produced by the analysis of the regionally
averaged time-course data. A log-linear pattern is evident in Figure 5. MSEs
vary by region, with larger regions having smaller MSEs. An analysis of the
MSE data leads to
log(MSElk) =
∑
k
βk · Ilk − γa · log(κlk) + γM ·Mlk + elk,(17)
where κlk is dose level, Ilk is the region indicator for region k and Mlk is
an indicator of whether the estimator was evaluated by analysis of averaged
time-course data or not. The modeling error is elk.
Table 1 reports estimated values for the γa-coefficients. For FDG the
γˆa ≈ 1.0, consistent with what one might expect in theory (see below).
A slower rate (γˆa ≈ 0.8) is indicated for H2O, a reflection of the larger num-
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(a) FDG simulation
Fig. 5. Sample time activity curve data (dots), together with the true (solid red) and
fitted model (broken red) and the corresponding residues (blue)—1 (Voxel data), 2 and
3 (ROI data). Mean square error values (averaged over 50 replicates) for the residue 4
and two other parameters, 5 and 6 (flux and distribution volume for FDG and flow and
distribution volume for H2O) plotted against dose (κ) for different regions. Regions are
represented by separate symbols.
ber of time frames (42 for H2O versus 31 for FDG) and the greater noise
arising from the rapid decay of the 15O isotope. Larger regions generally
have lower MSEs, but the heterogeneity of the region plays a role. As re-
gards comparison between regional kinetic quantification by analysis of the
averaged time course for the ROI or the averaging of voxel-level residues,
there is little difference. With H2O there is some small (1%) degradation in
MSE obtained by analysis of the average time-course data for the region;
a similar result holds for Flux in FDG, although this is not the case for
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(b) H2O simulation
Fig. 5. (Continued).
Table 1
MSE Characteristics for estimation of regional residues—parameters defined in the
model in equation (17). R2 values (adjusted) are from the model fit
Variable γa γM R
2
FDG
Residue 0.96 (±0.02) −0.03 (±0.02) 0.99
Flux 0.88 (±0.02) 0.05 (±0.02) 0.99
VD 0.98 (±0.02) −0.01 (±0.02) 0.98
H2O
Residue 0.76 (±0.04) 0.01 (±0.04) 0.84
Flow 0.66 (±0.07) 0.01 (±0.08) 0.98
VD 0.95 (±0.02) 0.01 (±0.02) 0.99
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integrated squared error of the residue or the volume of distribution. This
result supports mapping voxel-level residues because it allows subsequent
analysis of regions of interest to be simply achieved by direct application of
ROIs to voxel-level residue information.
Theoretical interpretation of results. At high doses MSE can be expected
to be dominated by variance. Since equation (16) is a linear model, the
covariance of the estimated α-coefficients at the ith voxel, which are ob-
tained by a weighted least squares procedure, will be approximated by
Σα ≈ φ2[X ′WX]−1, where
X ′WXjj′ =
∑
b
wbµ¯jb(∆ˆ)µ¯j′b(∆ˆ)
and wb =
∑
j αˆj µ¯jb(∆ˆ). Here, to simplify the notation, we have dropped the
subscripts i and k. This variance approximation will become more reliable
at high doses when the constraints on the α-coefficients are, typically, not
active. Recall from equation (7), µ¯jb involves the convolution of the normal-
ized residue R¯j and the arterial input function, Cp. So if Cp is expressed as
Cp = κC¯p where C¯p has amplitude of unity, Σα can be expressed as
Σα = κ
−1φ2[X¯ ′W¯ X¯]−1,(18)
with X¯ ′W¯ X¯ the same as X ′WX but with µ¯jb now involving convolution of
the normalized residue and normalized arterial input C¯p. Thus, at high doses
the variance and, consequently, the MSE, will be inversely proportional to
dose (κ). This is consistent with γˆa ≈ 1, as was found for FDG in the sim-
ulation. The slower convergence (γˆa ≈ 0.8) for H2O may be a reflection of
a greater dependence on constraints, due to the higher noise. When con-
straints are active, the standard weighted least squares covariance formula
will not be reliable.
6. Discussion. We have presented an approach to the estimation of voxel-
level tracer residues from PET time-course data. The technique uses a data-
adaptive mixture model that allows for voxel-level variation in the time of
arrival of the tracer in the arterial supply. The mixture representation of
local residues is plausible and has been used previously with basis residues
that are a compartmental model or have simple exponential forms [Cun-
ningham and Jones (1993) and O’Sullivan (1993)]. The present work shows
that it is possible to also use nonparametric forms for the basis residues.
This allows the possibility to better investigate potential deviations from
compartmental-like descriptions of tissue residues. Computationally, the lin-
earity of mixture models is attractive, as it facilitates the implementation
based on efficient use of standard quadratic programming tools. The work
has a reliance on multivariate statistical methods and uses backward elimi-
nation guided by an unbiased risk type model selection statistic.
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Residue functions are life tables for the transit time of radiotracer atoms.
Just as infant and elderly mortality patterns might be given separate atten-
tion in a human life table, decomposition of the residue can provide insight
into the tracer kinetics. Our approach emphasizes decomposition of residue
to focus on flow and volume characteristics of vascular and in distribution
transport as well as the (apparent) rate of extraction of the tracer by tis-
sue, that is, flux. Thus, we have a 5-number summary for the residue. The
life-table perspective on the tissue residue emphasized in this paper may
encourage broader interest in adapting methods from mainstream survival
analysis for application to the growing needs for quantitation in PET studies
and for related contrast tracking techniques used in computerized tomogra-
phy and magnetic resonance [Schmid et al. (2009)].
PET imaging has grown in importance particularly in the context of can-
cer, where over 90% of clinical imaging with PET is carried out. Having more
sophisticated kinetic analysis tools, such as residue analysis, can enhance the
type of information recovered from these studies. This may potentially lead
to better procedures for selecting and monitoring cancer treatments in or-
der to optimize the patient outcomes. A number of current clinical imaging
trails with PET in cancer already have reliance on detailed kinetic analysis
for extraction of diagnostic information. Given the nature of the problems
involved, there is an opportunity for statistics to play a greater role in these
developments.
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